Evidence map›Paper›PMID 41256845›Full record

ArticleFrontiers in immunology2025

Synergistic nano-vaccine strategy for comprehensive activation of adaptive and innate immunity against

Jiayue Xi, Minxuan Cui, Zhuoyue Shi, Zhuo Wan, Yufei Hou, Nan Sun, Muqiong Li, Zhengjun Ma, Yupu Zhu, Xin He and 5 more

Erratum issuedAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors.

Jiayue Xi *Shaanxi Key Laboratory of Chiral Drug and Vaccine Adjuvants, Department of Pharmaceutical Chemistry, Air Force Medical University, Xi'an, China.
Minxuan Cui *Shaanxi Key Laboratory of Chiral Drug and Vaccine Adjuvants, Department of Pharmaceutical Chemistry, Air Force Medical University, Xi'an, China.
Zhuoyue ShiShaanxi Key Laboratory of Chiral Drug and Vaccine Adjuvants, Department of Pharmaceutical Chemistry, Air Force Medical University, Xi'an, China.
Zhuo WanDepartment of Hematology, Tangdu Hospital, Air Force Medical University, Xi'an, China.
Yufei HouShaanxi Key Laboratory of Chiral Drug and Vaccine Adjuvants, Department of Pharmaceutical Chemistry, Air Force Medical University, Xi'an, China.
Nan SunShaanxi Key Laboratory of Chiral Drug and Vaccine Adjuvants, Department of Pharmaceutical Chemistry, Air Force Medical University, Xi'an, China.
Muqiong LiShaanxi Key Laboratory of Chiral Drug and Vaccine Adjuvants, Department of Pharmaceutical Chemistry, Air Force Medical University, Xi'an, China.
Zhengjun MaShaanxi Key Laboratory of Chiral Drug and Vaccine Adjuvants, Department of Pharmaceutical Chemistry, Air Force Medical University, Xi'an, China.
Yupu ZhuShaanxi Key Laboratory of Chiral Drug and Vaccine Adjuvants, Department of Pharmaceutical Chemistry, Air Force Medical University, Xi'an, China.
Xin HeShaanxi Key Laboratory of Chiral Drug and Vaccine Adjuvants, Department of Pharmaceutical Chemistry, Air Force Medical University, Xi'an, China.
Qian YangDepartment of Chinese Materia Medical and Natural Medicines, School of Pharmacy, Air Force Medical University, Xi'an, China.
Zhuojun ShiTeaching and Research Support Center, Airforce Medical Univeristy, Xi'an, China.
Huifang NieShaanxi Key Laboratory of Chiral Drug and Vaccine Adjuvants, Department of Pharmaceutical Chemistry, Air Force Medical University, Xi'an, China.
Chaojun SongSchool of Life Science, Northwestern Polytechnical University, Xi'an, China.
Li FanShaanxi Key Laboratory of Chiral Drug and Vaccine Adjuvants, Department of Pharmaceutical Chemistry, Air Force Medical University, Xi'an, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

For decades,

Indexed as

Adaptive ImmunityImmunity, InnateNanoparticlesStaphylococcal InfectionsStaphylococcal VaccinesStaphylococcus aureusAdjuvants, ImmunologicAnimalsAntibodies, BacterialAntigens, BacterialFemaleMiceNanovaccinesAdjuvants, ImmunologicAntibodies, BacterialAntigens, BacterialNanovaccinesStaphylococcal Vaccinescombination nanovaccinecomprehensive immune responsesESAT-6-like antigensPLGA nanoparticleStaphylococcus aureus

Identifiers

PMID41256845
PMCPMC12620494

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.